Smith & Nephew plc vs Utilities Select Sector SPDR Fund — how do they compare? Smith & Nephew plc trades at $29.55 (market cap $12.54B), while Utilities Select Sector SPDR Fund trades at $43.85. The key difference: Smith & Nephew plc pays a 2.65% dividend while Utilities Select Sector SPDR Fund pays none, and Utilities Select Sector SPDR Fund is trading nearer its 52-week high, Smith & Nephew plc nearer its low. Which is the better fit depends on your goals.
| SNN | XLU | |
|---|---|---|
Market Cap | $12.54B | — |
Sector | Health | — |
52-Week High | $38.70 | $47.73 |
52-Week Low | $28.73 | $41.31 |
Enterprise Value | $15.57B | — |
Dividend Yield | 2.65% | — |
Signals from Pluang's Aura AI — not financial advice
Smith & Nephew (SNN) trades at $30.08, down 0.1% with bearish technical signals. The company reported mixed Q2 2026 results with revenue growth below expectations, leading to a reduced full-year outlook. Fundamentals show strong profitability with 10.1% net margin and improving cash flow trends, though recent earnings misses have tempered sentiment.
Outlook remains cautious with analyst consensus at Hold (65% of coverage). Near-term risks include U.S. orthopedics weakness and competitive pressures, offset by robotics innovation and value-based care expansion. The stock offers stable fundamentals but faces execution challenges in key markets.
XLU trades at $43.74, up 1.39% with bearish technical signals from moving averages and oscillators. The ETF shows strong institutional call option activity, with 43,489 contracts traded on August 11, 2026, representing an 18% increase over typical volume. Recent news highlights XLU's positioning as an AI power demand play, with utilities gaining attention for data center electricity needs. The fund offers defensive income characteristics with dividend distributions scheduled for June 2026.
XLU faces technical headwinds but benefits from structural AI power demand growth. The ETF's defensive utility holdings provide income stability while capturing electricity infrastructure expansion. Key risks include interest rate sensitivity and regulatory changes, but institutional interest in call options suggests bullish positioning on the AI power theme.
Trailing returns across standard periods
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →